Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Qualigen Therapeutics, Inc. (QLGN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.5220-0.0477 (-8.37%)
At close: 04:00PM EDT
0.5510 +0.03 (+5.56%)
After hours: 07:23PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.5697
Open0.5500
Bid0.5201 x 1800
Ask0.5300 x 1800
Day's Range0.5159 - 0.5600
52 Week Range0.4500 - 3.1200
Volume189,526
Avg. Volume1,180,967
Market Cap18.42M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Benzinga

    Qualigen Takes Stake In NanoSynex To Gain Access To Next-Gen Diagnostic Platform

    Qualigen Therapeutics Inc (NASDAQ: QLGN) has agreed to acquire a majority stake in NanoSynex Ltd, an Israeli-based developer of next-generation diagnostics technology. NanoSynex's Antimicrobial Susceptibility Testing (AST) platform provides rapid, accurate, and personalized tests for bacterial infections to quickly match the correct antibiotics to treat a patient's particular infection. Antibiotic misuse and overuse have given rise to antibiotic-resistant bacteria, commonly known as superbugs. T

  • Simply Wall St.

    Here's Why Qualigen Therapeutics (NASDAQ:QLGN) Must Use Its Cash Wisely

    Just because a business does not make any money, does not mean that the stock will go down. For example, although...

  • Benzinga

    4 Penny Stocks Insiders Are Buying

    When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. CASI Pharmaceuticals The Trade: CASI Pharmaceuticals, Inc. (NASDAQ: CASI) Chairman & CEO Wei-Wu He acquired a total of 480

Advertisement
Advertisement